Skip to main navigation

A world of opportunity - Ernst & Young - Switzerland

HomeMonthly NewsApril 2008Publications
Monthly News
Ernst & Young Monthly News April 2008

Publications

Transfer Pricing Global Reference Guide 2008

(PDF, English, 622 kB)

Ernst & Young's Transfer Pricing Global Reference Guide is a comprehensive tool that is designed to help international tax executives to quickly identify the transfer pricing rules, practices, and approaches that have been adopted by over 40 countries. Bookmark the page for the latest developments and commentary on transfer pricing.

Swiss auditing standard (AS 890) - Requiring auditors to check for the existence of an internal control system

(PDF, german, 79 kB)

Summary of key provisions.

LOHAS - Lifestyle of Health and Sustainability

(PDF, English, German, 3.33 MB)

For this study, an independent marketing institute was assigned to survey over 700 consumers across Switzerland on the relevance of a number of health and sustainability issues to their buying decisions.

IPO Insights: Comparing Global Stock Exchanges

(PDF, English, 5.08 MB)

This report is designed to be an objective, fact-based comparative tool for business leaders weighing exchange alternatives. The scope encompasses the Australian Stock Exchange, Deutsche Börse, Euronext, Hong Kong Stock Exchange, London Stock Exchange, NASDAQ, New York Stock Exchange, Singapore Stock Exchange, and Tokyo Stock Exchange.

IPO Insights: SWX Swiss Exchange

(PDF, English, 164 kB)

This publication aims at giving an in-depth look at the SWX Swiss Exchange and should be seen as complementary to the Ernst & Young IPO Insights: Comparison Global Stock Exchanges report.

Progressions: Transforming Finance for Peak Performance (Part I)

(HTML, English)

Progressions: Transforming Finance for Peak Performance: Part I is the fifth issue in the Global Pharmaceutical Center's Progressions series. Given the importance and complexity of our current topic – the evolving role of the CFO in pharmaceutical companies – the Global Pharmaceutical Sector will devote two issues to it. This first report is focused on finance transformation in the pharmaceutical sector and the critical role of the finance function in driving the business transformation that is now at the forefront of C-suite and boardroom discussions

Related content
Other publications

Find further publications of Ernst & Young under

 
Subscribe

You can subscribe to this and future newsletters from Ernst & Young by clicking on

Ernst & Young Online

Learn more
 
-->
-->
Back to top